Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Max Greenberg
KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination With PI3K Inhibition.
Clinical Cancer Research
Cancer Research
Oncology
Related publications
KRAS Mutation as a Resistance Mechanism to BRAF/MEK Inhibition in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Combination PI3K/MEK Inhibition Promotes Tumor Apoptosis and Regression in PIK3CA Wild-Type, KRAS Mutant Colorectal Cancer
Cancer Letters
Cancer Research
Oncology
Direct Inhibition of Oncogenic KRAS by Hydrocarbon-Stapled SOS1 Helices
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
BET Inhibition Is an Effective Approach Against KRAS-driven PDAC and NSCLC
Oncotarget
Oncology
Allele-Specific Inhibitors Inactivate Mutant KRAS G12C by a Trapping Mechanism
Science
Multidisciplinary
Philosophy of Science
History
Targeting Pathways Downstream of KRAS in Lung Adenocarcinoma
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination With Vorinostat in KRAS-Mutant Colorectal Cancer Models
Clinical Cancer Research
Cancer Research
Oncology
SREBP1 Regulates Mitochondrial Metabolism in Oncogenic KRAS Expressing NSCLC
Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 Kinase in KRAS -Mutant Lung Cancer
Cancer Discovery
Oncology